Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: Preliminary data from a multicentre, prospective, open label trial

Multiple Sclerosis Journal

Volumn 17, Issue 12, 2011, Pages 1514-1519

  Gobbi, C ^a   Digesu, G A ^a,b,c   Khullar, V ^b   El Neil, S ^c   Caccia, G ^a   Zecca, C ^a  

^a REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^b ST MARY S HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

lower urinary tract symptoms; multiple sclerosis; neuromodulation; tibial nerve stimulation

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; FEMALE; HUMAN; LOWER URINARY TRACT SYMPTOM; MALE; MICTURITION; MULTICENTER STUDY; MULTIPLE SCLEROSIS; NERVE STIMULATION; PATIENT SATISFACTION; POSTERIOR TIBIAL NERVE; QUALITY OF LIFE; QUESTIONNAIRE; TREATMENT RESPONSE; ULTRASOUND;

EID: 82255170256     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511414040     Document Type: Article

References (34)

1. Fingerman JS, Finkelstein LH. The overactive bladder in multiple sclerosis. J Am Osteopath Assoc. 2000 ; 100: S9 - S12
2. Brubaker L. Urgency: the cornerstone symptom of overactive bladder. Urology. 2004 ; 64: 12-16 (Pubitemid 40038569)
3. Henze T, Rieckmann P, Toyka KV. Symptomatic treatment of multiple sclerosis. Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society. Eur Neurol. 2006 ; 56: 78-105 (Pubitemid 44492163)
4. Duthie J, Wilson DI, Herbison GP, Wilson D. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev. 2007 ;: CD005493
5. Nicholas RS, Friede T, Hollis S, Young CA. Anticholinergics for urinary symptoms in multiple sclerosis. Cochrane Database Syst Rev. 2009 ;: CD004193
6. Roxburgh C, Cook J, Dublin N. Anticholinergic drugs versus other medications for overactive bladder syndrome in adults. Cochrane Database Syst Rev. 2007 ;: CD003190
7. Van Kerrebroeck PE. Advances in the role of sacral nerve neuromodulation in lower urinary tract symptoms. Int Urogynecol J Pelvic Floor Dysfunct. 2010 ; 21: S467 - S474
8. Finazzi-Agro E, Petta F, Sciobica F, Pasqualetti P, Musco S, Bove P. Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial. J Urol. 2010 ; 184: 2001-2006
9. Schafer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn. 2002 ; 21: 261-274 (Pubitemid 34411846)
10. Coyne KS, Matza LS, Kopp Z, Abrams P. The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder. Eur Urol. 2006 ; 49: 1079-1086 (Pubitemid 43673993)
11. Cartwright R, Srikrishna S, Cardozo L, Robinson D. Validity and reliability of the patient's perception of intensity of urgency scale in overactive bladder. BJU Int. 2011 ; 107 (10). 1612-1617
12. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol. 1997 ; 104: 1374-1379 (Pubitemid 27517634)
13. Poston GJ, Joseph AE, Riddle PR. The accuracy of ultrasound in the measurement of changes in bladder volume. Br J Urol. 1983 ; 55: 361-363 (Pubitemid 13076306)
14. Hennessey A, Robertson NP, Swingler R, Compston DA. Urinary, faecal and sexual dysfunction in patients with multiple sclerosis. J Neurol. 1999 ; 246: 1027-1032
15. Koldewijn EL, Hommes OR, Lemmens WA, Debruyne FM, van Kerrebroeck PE. Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis. J Urol. 1995 ; 154: 169-173
16. Giannantoni A, Scivoletto G, Di Stasi SM, Grasso MG, Finazzi Agro E, Collura G, et al. Lower urinary tract dysfunction and disability status in patients with multiple sclerosis. Arch Phys Med Rehabil. 1999 ; 80: 437-441 (Pubitemid 29171959)
17. Roe B, Williams K, Palmer M. Bladder training for urinary incontinence in adults. Cochrane Database Syst Rev. 2000 ;: CD001308
18. De Ridder D, Vermeulen C, Ketelaer P, Van Poppel H, Baert L. Pelvic floor rehabilitation in multiple sclerosis. Acta Neurol Belg. 1999 ; 99: 61-64
19. Hay-Smith EJ, Bo Berghmans LC, Hendriks HJ, de Bie RA, van Waalwijk van Doorn ES. Pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev. 2001 ;: CD001407
20. Hoverd PA, Fowler CJ. Desmopressin in the treatment of daytime urinary frequency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 1998 ; 65: 778-780 (Pubitemid 28486663)
21. Valiquette G, Herbert J, Maede-D'Alisera P. Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind, crossover trial. Arch Neurol. 1996 ; 53: 1270-1275 (Pubitemid 26425073)
22. Dasgupta P, Haslam C, Goodwin R, Fowler CJ. The 'Queen Square bladder stimulator': a device for assisting emptying of the neurogenic bladder. Br J Urol. 1997 ; 80: 234-237 (Pubitemid 28318888)
23. De Ridder D, Chandiramani V, Dasgupta P, Van Poppel H, Baert L, Fowler CJ. Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long-term followup. J Urol. 1997 ; 158: 2087-2092 (Pubitemid 27481333)
24. Ouslander JG, Schnelle JF, Uman G, Fingold S, Nigam JG, Tuico E, et al. Does oxybutynin add to the effectiveness of prompted voiding for urinary incontinence among nursing home residents? A placebo-controlled trial. J Am Geriatr Soc. 1995 ; 43: 610-617
25. Kabay S, Kabay SC, Yucel M, Ozden H, Yilmaz Z, Aras O, et al. The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis-related neurogenic bladder dysfunction. Neurourol Urodyn. 2009 ; 28: 964-968
26. Kabay SC, Yucel M, Kabay S. Acute effect of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with multiple sclerosis: urodynamic study. Urology. 2008 ; 71: 641-645 (Pubitemid 351442981)
27. Kohli N, Rosenblatt PL. Neuromodulation techniques for the treatment of the overactive bladder. Clin Obstet Gynecol. 2002 ; 45: 218-232 (Pubitemid 34212425)
28. Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010 ; 183: 1438-1443
29. Peters KM, Macdiarmid SA, Wooldridge LS, Leong FC, Shobeiri SA, Rovner ES, et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol. 2009 ; 182: 1055-1061
30. De Seze M, Raibaut P, Gallien P, Even-Schneider A, Denys P, Bonniaud V, et al. Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study. Neurourol Urodyn. 2011 ; 30: 306-311
31. Vandoninck V, van Balken MR, Finazzi Agro E, Heesakkers JP, Debruyne FM, Kiemeney LA, et al. Posterior tibial nerve stimulation in the treatment of voiding dysfunction: urodynamic data. Neurourol Urodyn. 2004 ; 23: 246-251 (Pubitemid 39549984)
32. Finazzi-Agro E, Rocchi C, Pachatz C, Petta F, Spera E, Mori F, et al. Percutaneous tibial nerve stimulation produces effects on brain activity: study on the modifications of the long latency somatosensory evoked potentials. Neurourol Urodyn. 2009 ; 28: 320-324
33. Peters K, Carrico D, Burks F. Validation of a sham for percutaneous tibial nerve stimulation (PTNS). Neurourol Urodyn. 2009 ; 28: 58-61
34. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 ; 33: 1444-1452 (Pubitemid 14237132)